MarketContraceptive implant
Company Profile

Contraceptive implant

A contraceptive implant is an implantable medical device used for the purpose of birth control. The implant may depend on the timed release of hormones to hinder ovulation or sperm development, the ability of copper to act as a natural spermicide within the uterus, or it may work using a non-hormonal, physical blocking mechanism. As with other contraceptives, a contraceptive implant is designed to prevent pregnancy, but it does not protect against sexually transmitted infections.

Women
Implant The contraceptive implant is hormone-based and highly effective, approved in more than 60 countries and used by millions of women around the world. The typical implant is a small flexible tube measuring about in length. It is most commonly inserted subdermally in the inner portion of the upper, non-dominant arm by a trained and certified health care provider. After insertion, it prevents pregnancy by releasing progestin which inhibits ovulation. The two most common versions are the single-rod etonogestrel implant and the two-rod levonorgestrel implant. Brands include: Norplant, Jadelle (Norplant II), Implanon, Nexplanon, Sino-implant (II), Zarin, Femplant and Trust. Benefits Some brands of the contraceptive implant, including Nexplanon, are over 99% effective. The benefits of the contraceptive implant are dependent on the active ingredients. Depending on the type of implant, benefits of the implant may include fewer, lighter periods, improved symptoms of premenstrual syndrome, long-lasting up to three to five years, and the convenience of not needing to remember to use it every day. The implant is also useful for women who cannot use contraception that contains oestrogen. The implant can also be removed at any time and natural fertility will return very quickly. Side effects When the implant is first inserted, it is common to have some bruising, tenderness or swelling around the implant. Although rare, there is also a risk of complications occurring during insertion or removal of the implant. contraceptive also corresponds with earlier waking, frequent mood swings, impaired concentration, and strain. The Implanon also has these negative side effects causing a considerable amount of vaginal bleeding irregularities, and amenorrhea in about 30–40% of its users during the following 90 days of starting use. However, there may be little or no difference between immediate and delayed insertion in terms of continued use of implants at six months or in terms of women's satisfaction, Progestin containing implants (specifically etonogestrel) are safe for immediate insertion in both postpartum individuals and those post-abortion. As of 2011, IUDs are the most widely used form of reversible contraception worldwide. Among types of birth control they, along with birth control implants, result in the greatest satisfaction among users. IUDs also tend to be one of the most cost-effective methods of contraception for women. Cons of intrauterine devices, similarly to implants, is the need for a trained healthcare professional for both insertion and removal. Brands include: Paragard, Kyleena, Liletta, Mirena, and Skyla. Hormonal IUD Hormonal IUDs contain the hormone levonorgestrel which is a progestin. Most commonly, products are inserted for 5 years, allowing them to release a low dose of hormones over that time frame. The levonorgestrel IUD is highly efficacious and has a failure rate of only 0.2% in the first year of use. An additional benefit of hormonal IUDs is decreased blood loss, which 20-30% of patients will experience amenorrhea. The disadvantage of this immediate insertion is the associated higher risk of expulsion or uterine perforation, however, the benefits greatly outweigh any potential risk. They also are safe to use in lactation. An additional benefit of copper IUDs is their use in emergency contraception. Not only are they able to be used as a form of emergency contraception but a Cochrane review noted that they are the most effective method of emergency contraception as well. When inserted within 7 days of unprotected intercourse, they are able to reduce the risk of pregnancy by 99% and provide the added benefit of ongoing contraception in the patient too. ==Men==
Men
Several barriers exist to expanding research into implantable and other contraceptive methods for men, including vague regulatory guidelines, long device development timelines, men's attitudes towards convenience, and a significant lack of funding. Several implantable devices have been attempted, both hormonal and non-hormonal. Research In 2001, Dutch pharmaceutical company Organon announced clinical trials of its implantable etonogestrel-based male contraceptive would begin in Europe and the U.S., anticipating a marketable product as early as 2005. Despite promising results, research development stopped, with outside speculation that lack of marketability was a factor. Organon representative Monique Mols stated in 2007 that "[d]espite 20 years of research, the development of a [hormonal] method acceptable to a wide population of men is unlikely". Schering/Bayer had been working on a similar annual implant with quarterly injections but cancelled the research in 2006/2007, Clinical trials were set to begin in 2011 or 2012, In January 2016, news broke of a non-hormonal, implantable valve—the Bimek SLV. It included a switch that attaches to the vas deferens, allowing the owner to stop and resume the flow of sperm on demand. A clinical trial of 25 participants was announced to further test the efficacy of the device. ==Other animals==
Other animals
Implantable contraception is also an option for animals, particularly for animal managers at zoos and other captive animal facilities who require reversible contraception methods for managing population growth in limited captive habitat. The Association of Zoos and Aquariums' (AZA) Reproductive Management Center (formerly known as the AZA Wildlife Contraception Center) at the Saint Louis Zoo in St. Louis, Missouri, has played a major role in researching and disseminating contraception information, via its Contraception Database. It houses over 30,000 records for hundreds of species. One of the most popular contraceptive methods used by zoos (as well as in domestic animals) is the melengestrol acetate (MGA) implant, a progestin-based hormonal contraceptive developed in the mid-1970s. Other progestin-based implants that have been placed in animals include Norplant, Jadelle, and Implanon. Androgen-based implants that use agonist (stimulating) gonadotropin-releasing hormone (GnRH) and, to a lesser degree, IUDs have also seen use in several domestic and exotic species. Whatever the implant, some care must be taken to minimize the risk of implant migration or loss. ==References==
tickerdossier.comtickerdossier.substack.com